New crown nucleic acid positive, taking chloroquine phosphate is only effective for some patients, may turn negative, but does not belong to the new crown pneumonia diagnosis and treatment norms.
Chloroquine phosphate is commonly used in the treatment of malaria, amoebiasis, connective tissue disease, etc. It may cause dizziness, abdominal pain and diarrhea, hearing impairment, cardiac arrhythmia and other adverse reactions, and is contraindicated in pregnant women.
A person can be determined to be infected with the Neocoronavirus if the result of the Neocoronavirus nucleic acid test is positive. Previously, there were relevant clinical trials using chloroquine phosphate to treat positively infected patients, and some infected patients were able to achieve a negative result in 4~5 days, but there were no controlled trials, and it has not been formally entered into the clinic.
Therefore, there is no authoritative basis for the use of chloroquine phosphate in nucleic acid-positive patients to achieve a negative result, and it is necessary to consult a doctor in time for regular treatment.
Tips] The “new coronary pneumonia, new coronary virus pneumonia” mentioned in this article has been renamed to “new coronary virus infection” on December 26, 2022, as announced by the National Health Commission.